Pauline McGowan

Pauline McGowan joined Cygnal Therapeutics in January 2019 as Senior Vice President of Finance. She has more than 20 years of financial planning, accounting, and operational experience in the life sciences industry. Most recently, Pauline served as Head of Finance at Ginkgo Bioworks during a period of rapid growth, including a $275M Series D financing and $100M joint venture with Bayer. Prior to Ginkgo Bioworks, Pauline served as Vice President of Finance at Concert Pharmaceuticals. She played a lucrative role in joining the privately held biotech company in 2007, while also managing its governance and SEC Compliance through S-1 filing and successful IPO. She began her professional career at PricewaterhouseCoopers LLP.

Pauline holds a B.S. in Business Administration from Villanova University and was licensed as a Certified Public Accountant in Massachusetts.

Pauline McGowan headshot

Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.